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ABSTRACT
The caterpillar fungus Ophiocordyceps sinensis (syn.† Cordyceps sinensis), which was originally used in traditional Tibetan and 
Chinese medicine, is called either “yartsa gunbu” or “DongChongXiaCao (冬蟲夏草 Dōng Chóng Xià Cǎo)” (“winter worm-
summer grass”), respectively. The extremely high price of DongChongXiaCao, approximately USD $20,000 to 40,000 per kg, 
has led to it being regarded as “soft gold” in China. The multi-fungi hypothesis has been proposed for DongChongXiaCao; 
however, Hirsutella sinensis is the anamorph of O. sinensis. In Chinese, the meaning of “DongChongXiaCao” is different for O. 
sinensis, Cordyceps spp.,‡ and Cordyceps spƒ. Over 30 bioactivities, such as immunomodulatory, antitumor, anti-inflammatory, 
and antioxidant activities, have been reported for wild DongChongXiaCao and for the mycelia and culture supernatants of 
O. sinensis. These bioactivities derive from over 20 bioactive ingredients, mainly extracellular polysaccharides, intracellular 
polysaccharides, cordycepin, adenosine, mannitol, and sterols. Other bioactive components have been found as well, including 
two peptides (cordymin and myriocin), melanin, lovastatin, γ-aminobutyric acid, and cordysinins. Recently, the bioactivities of 
O. sinensis were described, and they include antiarteriosclerosis, antidepression, and antiosteoporosis activities, photoprotection, 
prevention and treatment of bowel injury, promotion of endurance capacity, and learning-memory improvement. H. sinensis 
has the ability to accelerate leukocyte recovery, stimulate lymphocyte proliferation, antidiabetes, and improve kidney injury. 
Starting January 1st, 2013, regulation will dictate that one fungus can only have one name, which will end the system of using 
separate names for anamorphs. The anamorph name “H. sinensis” has changed by the International Code of Nomenclature for 
algae, fungi, and plants to O. sinensis.
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Notification
†The term “Cordyceps sinensis” has been renamed to its synonym “Ophiocordyceps sinensis” by Sung et al. in 2007. In the 
discussion, “Cordyceps sinensis” is still used to represent “Ophiocordyceps sinensis” out of respect to the original authors of 
the articles that we cited.
‡Cordyceps spp. indicates any species that belongs to the genus Cordyceps.
ƒCordyceps sp. indicates the unidentified species that belong to the genus Cordyceps
This is an open access article under the CC BY-NC-ND license.
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INTRODUCTION
The caterpillar fungus Ophiocordyceps sinensis (syn. Cordy-
ceps sinensis) is one of the entomogenous Ascomycetes and 
parasitizes the larvae of Lepidoptera to form the well-known 
traditional Tibetan medicine “yartsa gunbu” or, in traditional Chi-
nese medicine, “DongChongXiaCao (冬蟲夏草 Dōng Chóng Xià 
Cǎo)”(“winter worm-summer grass,” [Figure 1]). DongChongXi-
aCao is a well-described remedy that has been used in traditional 
Chinese medicine for over 700 years.[1] The wild fungus, which 
possesses a plant-like fruiting body and originates from dead 
caterpillar that fill with mycelia [Figure 2], has generally been 
called C. sinensis or Cordyceps spp. (“ChongCao” in Chinese) 
due to its insect-shape appearance. O. sinensis (previously named 
C. sinensis) is a slow-growing fungus and needs to be grown at a 
comparatively low temperature, i.e., below 21ºC. Both temperature 
and growth rate are crucial factors that identify O. sinensis from 
other similar fungi.[2] In recent decades, curative and health-care 
products derived from the so-called “Cordyceps” are extremely 
popular in China in various forms such as capsules, oral liquids, 
and drinks.[3] Most of these products, derived from submerged my-
celial O. sinensis cultures [Figure 3], are the popular merchandise 
items on the market. 
It has been shown that O. sinensis can be used to treat condi-
tions such as hyposexuality, night sweats, hyperglycemia, hyper-
lipidemia, asthenia, arrhythmias, and other heart, respiratory, renal 
and liver diseases.[3] Although “natural O. sinensis specimens” 
have significant pharmaceutical effects, the commercial cultiva-
tion of this fungus on larvae of moth to produce fruiting body has 
not yet been successful.[4] Therefore, the biology of O. sinensis 
remains a secret, and its commercial cultivation is still a dream.[5]
In the past years, several new names have been proposed for O. 
sinensis-like species from alpine regions, such as O. gansuënsis, 
O. crassispora, O. kangdingensis, O. multiaxialis, O. nepalensis, 
and others, but there is not sufficient to distinguish these spe-
cies from O. sinensis.[6] Fungi other than O. sinensis originating 
Figure 2. Scanning electron micrograph of mycelia filling the inside of a 
fruiting body of wild DongChongXiaCao
Figure 1. Wild DongChongXiaCao (black part: the fruiting body; brown 
part: the caterpillar corpus)
Figure 3. Scanning electron micrograph of mycelia from the medium of 
a submerged culture of Ophiocordyceps sinensis
Figure 4. Label showing the precious price (CNY ¥698 per gram) of wild 
DongChongXiaCao sold in August, 2012 in Beijing, China
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from natural O. sinensis specimens could be important resources 
for the development of alternative products.[7] For example, it 
is claimed that the Bailing Capsule, a cultured product isolated 
from DongChongXiaCao, has a similar chemical composition to 
natural O. sinensis; in addition, the Bailing Capsule possesses 
anti-inflammatory, antihypoxia, and antitumor properties and has 
the ability to regulate the endocrine system, enhance immune 
function, and protect the kidneys, lung, liver, and other organs.[8] 
As a traditional oriental medicine, DongChongXiaCao 
is endemic to alpine habitats on the Tibetan Plateau, located 
predominantly in Tibet, the Tibetan autonomous prefectures of 
neighboring provinces, and the high Himalayas.[9] In recent years, 
DongChongXiaCao has been regarded as the Himalayan Viagra, 
which has caused the price to reach USD $6.77 per piece of 
wild medicine.[10] Over the past 10 years, its value has increased 
dramatically. For example, collectors must pay as much as USD 
$12,500 per kg for top-quality material.[11] In 2008-2009, the price 
of C. sinensis crude drug was around USD $13,000 per kg, which 
caused it to be regarded as “soft gold” in China.[12] Furthermore, it 
is believed that the price of this fungus reached USD $20,000 to 
40,000 per kg in the international market.[13] As of August 2012, 
the price per gram of wild DongChongXiaCao in Beijing is up 
to CNY ¥698 [Figure 4], or USD $111,560 per kg. This price 
already surpasses that of real gold. According to the government 
statistics for 2004, 50,000 kg of this drug were collected, which 
contributed more than USD $225 million to the Tibet Autonomous 
Region’s GDP,[14] these data suggested that about 40% of the 
rural cash income in the Tibet Autonomous Region comes from 
DongChongXiaCao collection. 
REVIEW ARTICLES AND SPECIAL REPORTS 
OF CORDYCEPS
Since 1998, there have been more than 25 reviews or special 
reports published discussing Cordyceps, and 14 of them have 
focused on C. sinensis. For example, these studies have empha-
sized: terminology, life strategy, and ecology;[5] traditional uses 
and medicinal potential in Sikkim;[10] the reliability of fungal ma-
terials;[2] ecology, trade, and development in Tibet;[15] production 
and sustainability on the Tibetan Plateau and in the Himalayas;[16] 
origin of scientific name, morphological characteristics, micromor-
phological characteristics of the teleomorph, identification, hosts, 
and synonymy;[6] ethnomycological use, collection, discovery, 
protection, and the range of diseases treated in Northern Yunnan 
Province in China;[9] host spectrum, distribution, artificial rearing 
host, infection technology, and substitute products;[17] clinical 
efficacy for chronic kidney diseases;[18] markers and analytical 
methods for quality control;[19] history, use, and implications;[20] 
pharmacological functions;[21] safety, effects on the nervous 
system, glucose metabolism, effects on the respiratory, hepatic, 
cardiovascular, immune systems, immunological disease, inflam-
matory conditions, cancer, and diseases of the kidney;[22] and in 
vitro and in vivo studies, open-label and double-blinded clinical 
trials on the respiratory, renal, hepatic, cardiovascular, immuno-
logical, and nervous systems, and in its effects on cancer, glucose 
metabolism, inflammatory conditions, and toxicological studies.
[23] Two papers have focused on C. militaris, placing emphasis on: 
biological aspects including the host range, mating system, cytol-
ogy and genetics, insect- and noninsect nutritional requirements, 
environmental influence on stroma development, and commercial 
development;[24] and active principles and culture techniques.[25] 
The other publications focus on Cordyceps, examining: pharma-
cological functions and development of products;[3] production, 
isolation, purification, structure elucidation, and pharmacological 
action of polysaccharide;[1] chemical constituents;[26] preparations 
and chemical structures of polysaccharide;[27] taxonomic concepts, 
preparations, apoptosis, chemical constituent profiling, hosts, and 
poisoning;[28] history, medicinal uses, chemical composition, and 
cultivation;[29] pharmacological actions;[30] and the pharmacological 
basis of “Yin-nourishing (養陰 Yǎng Yīn)” and “Yang-invigorating 
(壯陽 Zhuàng Yáng)” actions.[31]
TERMINOLOGY OF “DONGCHONGXIACAO” 
WITH REGARD TO CORDYCEPS
“DongChongXiaCao” is commonly known as “yarsa gumba” 
in Tibetan, because “yarsa” means winter and “gumba” means 
summer. “Gunba” or “gonba” has also been used to replace 
“gumba,” and the fungus is named “keera jhar” (insect herb) in 
the Indian mountains.[13]
However, the term “DongChongXiaCao” in Chinese has been 
recognized as having different meanings, as follows:
1. The traditional Chinese medicine originating from O. 
sinensis (syn. C. sinensis).
2. The health food originating from O. sinensis.
3. The fungus O. sinensis.
4. The fungi Cordyceps spp.
5. The fungus Cordyceps sp.
6. The fungi Ophiocordyceps spp.
7. The fungus Ophiocordyceps sp.
8. The wild and crude medicine that has a caterpillar shape 
with fruiting body.
9. The mycelia of O. sinensis derived from submerged 
culture.
10. The mycelia of H. sinensis derived from submerged 
culture.
11. The traditional Chinese medicine originating from the 
larvae of Hepialidae (Lepidoptera) infected by O. sinensis.
12. The traditional Chinese medicine originating from the lar-
vae of Thitarodes (syn. Hepialus) infected by O. sinensis.
13. The traditional Chinese medicine originating from the 
larvae of T. armoricanus (syn. H. armoricanus) infected 
by O. sinensis.
14. The traditional Chinese medicine originating from the 
larvae of Hepialidae (Lepidoptera) infected by Ophio-
cordyceps spp.
15. The traditional Chinese medicine originating from the 
larvae of Hepialidae (Lepidoptera) infected by Cordyceps 
spp.
The term “ChongCao” (meaning Insect Grass) in Chinese is 
Lo, et al. / Journal of Traditional and Complementary Medicine 3 (2013) 16-32
19
the abbreviation of “DongChongXiaCao,” which related products 
is popular in the market in Taiwan. For consumers, it is confusing 
whether “ChongCao” is equivalent to “DongChongXiaCao,” the 
traditional Chinese medicine “DongChongXiaCao,” or the fungi 
Cordyceps spp. In addition, C. militaris, a type species of Cordy-
ceps, has been regarded as a substitute for “DongChongXiaCao” 
and is named “North DongChongXiaCao,” “BeiChongCao,” 
“ChongCao mycelium,” or “ChongCao fruiting body.” There 
is no doubt that O. sinensis is not equivalent to the traditional 
Chinese medicine “DongChongXiaCao,” because the latter has 
a caterpillar shape with a fruiting body. In the market, natural 
products with caterpillar shapes and fruiting bodies that are called 
“DongChongXiaCao” are extensively distributed; however, the 
origins of most of these microorganisms and their hosts remain 
uncertain. In the scientific view, the traditional Chinese medicine 
wild “DongChongXiaCao” is not strictly equivalent to O. sinensis 
unless the species has been identified. In fact, for most literature, 
the term “C. sinensis” used in the materials section might refer 
to wild DongChongXiaCao or to its fruiting bodies or cultured 
mycelia. Dong and Yao[2] reviewed 152 papers from PubMed on 
O. sinensis since 1998 and found that at least 116 papers (over 
three-quarters) used unreliable, uncertain, or unspecified materials, 
including so-called cultivated fruit bodies that were apparently 
not O. sinensis strains, based on temperature and growth period.
RENAMING, ANAMORPH, AND GENETIC 
DIVERSIFICATION OF C. SINENSIS
Renaming of C. sinensis
The colony characteristics of O. sinensis cultures are significant 
different from Cordyceps spp. Mostly Cordyceps species possess 
brightly colored and fleshy stromata. The family of Cordycipita-
ceae has been validated based on the type species of Cordyceps, 
C. militaris, and a new family, Ophiocordycipitaceae, based on 
the Genus Ophiocordyceps Petch, the majority of whose species 
produce dark pigments and tough to pliant stromata, often pos-
sesses aperithecial apices including C. sinensis.[32] Based on the 
publication referenced above, C. sinensis has been transferred to 
Ophiocordyceps and has been renamed O. sinensis.
The anamorph of C. sinensis
Twenty-two names spanning 13 genera associated with the 
anamorph of C. sinensis have been described.[33] However, H. 
sinensis and C. sinensis belong to different stages of the life cycle 
of the same organism: H. sinensis is the anamorph of C. sinensis, 
rather than Paecilomyces sinensis or other species.[34] The rDNA 
ITS sequences of C. sinensis collected from different geographical 
regions are almost identical and are significantly different from 
substitutes.[35] H. sinensis has been confirmed as the anamorph of 
C. sinensis by both DNA sequences and microcyclic conidiation, 
and additionally, two species, C. multiaxialis and C. nepalensis, 
were shown to share identical or almost identical ITS sequences 
with C. sinensis.[36]
The relationship between teleomorphs of Cordyceps spp. and 
their presumed anamorphs has been investigated by analyzing 5.8S 
and ITS rDNA sequences. Both sequence analyzes demonstrated 
that H. sinensis is the anamorph of C. sinensis.[37] When analyzing 
the sequences of ITS1, ITS2 and 5.8S rDNA regions, some spe-
cies with different names had similar morphologies to C. sinensis, 
which suggested that these species might be synonymous with C. 
sinensis.[38] Based on the results of the 5.8S rDNA and ITS region 
analyses, it is clear that the ITS sequences within C. sinensis are 
highly homologous, regardless of the geographical origin. The 
evolutionary distance values between C. sinensis and H. sinensis 
were found to be the same as those for C. sinensis from different 
geographic regions, and C. sinensis should only have H. sinensis 
as its asexual stage, regardless of sample origin.[39] Even though 
many studies indicate that H. sinensis is the only anamorph of C. 
sinensis, molecular evidence demonstrates the existence of both 
H. sinensis and Paecilomyces hepiali DNA in the caterpillars and 
fruiting bodies of natural C. sinensis, strongly supports the multi-
fungi hypothesis for natural C. sinensis.[40]
Genetic diversification of C. sinensis 
A high diversity in the fungal community structure occurs 
in natural O. sinensis.[5] The significant genetic divergence in O. 
sinensis was found to be greater among southern isolates than 
among northern isolates in China.[41] The genetic similarity indices 
range from 0.282 to 0.782, which indicate that there is a high level 
of diversity among natural C. sinensis samples.[42] In addition, a 
total of 141 markers, 99.3% of which were polymorphic, were 
identified in 180 individual samples of natural C. sinensis from 
18 populations, and these 18 populations can be divided into five 
groups based on genetic distance and by grouping pattern matches 
with geographic distributions along the latitudinal gradient.[43] It 
has been observed that differences in medicinal effects among C. 
sinensis populations may be attributed to the existence of geneti-
cally differentiated chemotypes in morphotaxon.[44]
CHEMICAL CONSTITUENTS, PROXIMATE 
COMPOSITION AND VOLATILE COMPOUNDS 
Chemical constituents
The chemical constituents of natural Cordyceps include 
cordycepic acid, glutamic acid, amino acids, polyamines, cyclic 
dipeptides, saccharides and sugar derivatives, sterols, nucleotides 
and nucleosides, 28 saturated and unsaturated fatty acids, fatty 
acid derivatives and other organic acids, vitamins, and inorganic 
elements.[13] Palmitic acid, linoleic acid, oleic acid, stearic acid, 
and ergosterol are the main components of natural and cultured 
Cordyceps, these fatty acids, as well as 14 investigated compounds, 
can be used to discriminate the hierarchical cluster, as the palmitic 
acid and oleic acid contents in natural Cordyceps are significantly 
higher than those in the cultured Cordyceps.[45]
Proximate composition and others
Significant differences in proximate composition, such as for 
protein, fat, carbohydrate, and moisture content, were observed 
between the corpus and the fruiting body of wild DongChongXi-
aCao and the fermented mycelia of C. sinensis. There is a con-
spicuously high carbohydrate content of 39.4% for fermented 
mycelia, whereas carbohydrates comprise 24.20% of the corpus 
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and 24.9% of the fruiting body in wild DongChongXiaCao.[46] 
Fermented mycelia had lower protein and fat contents (14.8 and 
6.63%, respectively) than the corpus (29.1 and 8.62%, respec-
tively) and the fruiting body (30.4 and 9.09%, respectively) of 
wild DongChongXiaCao.[46] However, Smironv et al,[47] showed 
that the mycelia of C. sinensis had high protein (29%) and low 
lipid contents (7%), and, similar to other studies. They also in-
dicated that the mycelia were rich in endopolysaccharides (EPS, 
15%), phospholipids (up to 28% of total lipids), and unsaturated 
fatty acids (C18:1 - up to 44%; C18:2 - 53% of total fatty acids).
The compositions of natural fruiting bodies of C. sinensis 
(NFCS) and mycelia from submerged cultures (MSMC) and shak-
ing cultures (MSKC) of H. sinensis were compared by Li et al.[48] 
They indicated that the crude fat, crude protein, total, and essential 
amino acid contents could be ranked in the following descending 
order: MSKC > MSMC > NFCS, and additionally, unsaturated 
fatty acids in MSMC account for 65.9% of total fatty acids, which 
is noticeably lower than for NFCS (86.9%) and MSKC (76.5%). 
The total content of four nucleosides (adenosine, guanosine, urid-
nine, and inosine) in MSMC (6.20 mg/g) was significantly higher 
than NFCS (1.80 mg/g) and MSKC (1.60 mg/g).[48] Moreover, the 
sugar and protein contents of EPS from Hirsutella sp. were 92.7 
and 5.2%, respectively, and the monosaccharide components of 
EPS are mannose, galactose, and glucose with a molar ratio of 
4.0:8.2:1.0, and its molecular weight is 23 kDa.[49]
Volatile compounds
From the mycelia of H. sinensis cultured with solid-state media 
(SSM) and submerged fermentation (SF), 51 volatile compounds 
were identified, and phenols, acids, and alkanes were the major 
classes of compounds, while butylated hydroxytoluene was the 
most abundant volatile compound and accounted for 47.38% and 
46.12% of the total volatile compounds in mycelia cultured by 
SSM and SF, respectively.[50]
BIOACTIVE INGREDIENTS AND 
BIOACTIVITIES
A review of the literature regarding the bioactive ingredients 
and bioactivities of O. sinensis reveals that eight types of materi-
als have been used, including (1) the crude powder, (2) the crude 
powder of the fruiting body, (3) the extracts from the crude pow-
der, (4) the extracts from the crude powder of the fruiting body, 
(5) the crude powder of mycelia, (6) mycelial extracts, (7) the 
supernatants of submerged fermented cultures and (8) the whole 
broth of submerged fermented cultures. The diversity of these 
materials brings up the major concern of whether the knowledge 
we have acquired regarding O. sinensis is applicable to wild 
“Dong Chong Xia Cao” or the fermented mycelia or mycelial 
fermentation products (including cultured broth) of O. sinensis, 
H. sinensis, or other species.
Over 20 bioactive ingredients from mycelia, culture super-
natants, or fruiting bodies have been published, as shown in 
Table 1. In summary, these ingredients include (1) extracellular 
polysaccharides, (2) intracellular polysaccharides, (3) cordycepin, 
(4) adenosine, (5) guanosine, (6) cordymin, (7) lovastatin, (8) 
γ-aminobutyric acid (GABA), (9) sitosterol, (10) ergosterol, (11) 
ergosta-4,6,8(14),22-tetraen-3-one(ergone), (12) 5α,8α-epidioxy-
22E-ergosta-6,22-dien-3β-ol, (13) 5α, 8α- epidioxy-22E-ergosta-
6,9(11),22-trien-3β-ol, (14) 5α,6α-epoxy-5α-ergosta-7,22-dien-
3β-ol, (15) 5α,8α-epidioxy- 24(R)-methylcholesta-6,22-dien-3β-
D-glucopyranoside, (16) ,6-epoxy-24(R)-methylcholesta-7,22-
dien-3β-ol, (17) myriocin, (18) melanin, (19) cordysinin A, (20) 
cordysinin B, (21) cordysinin C, (22) cordysinin D, (23) cordysinin 
E, and (24) serine protease. 
The bioactivities of O. sinensis, which have been identified 
from materials derived from different preparations or extracts that 
were tested in in vitro, in vivo, or ex vivo studies, are shown in 
Table 2. Over 30 different bioactivities have been reported for O. 
sinensis, including (1) immunomodulatory, (2) immunosuppres-
sive, (3) anticomplementary, (4) antitumor, (5) anti-inflammatory, 
(6) antioxidant, (7) antibacterial, (8) hepatoprotection, (9) kidney 
benefitting, (10) antidiabetes, (11) hypocholesterolemia, (12) 
antiarteriosclerosis, (13) antithrombus, (14) hypotension and 
vasorelaxant, (15) lung benefitting, (16) photoprotection, (17) 
antidepression, (18) antiosteoporosis, (19) anticerebral ischemia, 
(20) antifatigue, (21) antiasthma, (22) steroidogenesis, (23) eryth-
ropoiesis, (24) antiarrhythmia, (25) antiaging, (26) testosterone 
production, (27) sedation, and (28) adjunction, as well as the ability 
to do the following: (29) prevent and treat injury to the bowel, (30) 
promote endurance capacity, (31) improve learning-memory, (32) 
prevent allograft rejection, and (33) attenuate lupus.
It has been found that most local folk/traditional healers use 
Cordyceps to treat 21 ailments, including erectile dysfunction, 
female aphrodisia, malignant tumors, bronchial asthma, bronchitis, 
diabetes, cough and cold, jaundice, alcoholic hepatitis, and others.[10] 
The traditional uses of caterpillar fungus among the Bai, Naxi, 
Lisu, and Tibetan people living in the mountainous Northern Yun-
nan Province are to improve eyesight, to treat calcium deficiency 
(specific to children), diabetes and associated nephropathy, and 
indigestion (specific to children), to speed up labor parturition, 
and to strengthen the immune system.[9] Moreover, C. sinensis 
exhibits broad biological and pharmacological actions in hepatic, 
renal, cardiovascular, and immunological systems, and possesses 
anticancer activity as well.[21]
Polysaccharides
Evidence indicates that Cordyceps polysaccharides may ef-
fectively improve immune system function and possess liver 
protection, antihyperglycemia, hyperlipidemia, antitumor and 
antioxidant activities.[1]
Extracellular polysaccharides
There are several different Extracellular polysaccharides 
(EPS) from O. sinensis that are based on their molecular weights 
(MW). EPS obtained from submerged O. sinensis culture super-
natant with MW ranging from 5 to 200 kDa has antioxidant and 
immunomodulatory activities and may attenuate renal failure, 
described as follows. The EPS designated EPS-1 with an average 
MW of 38 kDa was hydrolyzed in diluted sulfuric acid solution at 
pH 1 and 90°C to yield two major MW fractions: 3.0 kDa and 30 
kDa possessed high (30-80%) antioxidant and radical-scavenging 
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Table 1. Bioactive ingredients, bioactivities and material sources of O. sinensis 
No. Bioactive Ingredient Bioactivities Material Source References
1 Extracellular polysaccharides or exopolysaccharide Immunomodulatory and antitumor Culture supernatant [51-53]
Immunomodulatory [54-58]
Antioxidant Culture supernatant [59,60]
2 Intracellular polysaccharides Immunostimulatory and antitumor Mycelium [61]
Immunomodulatory and antioxidant Mycelium [62]
Immunomodulatory Mycelium [63-65]
Hypoglycemic Mycelium [66,67]
Hypoglycemic and antioxidant Mycelium [68]
Antioxidant and antitumor Mycelium [69]
Antioxidant Mycelium [70,71]
Antioxidant Fruiting body [72]
Protection of chronic renal failure Mycelium [73]
Cholesterol esterase inhibitory activity Mycelium [74]
Lower plasma triglyceride and cholesterol Mycelium [75]
3 Cordycepin Steroidogenesis Culture supernatant [76,77]
Antimetastatic activity Culture supernatant [78]
Antitumor Culture supernatant [79,80]
Immunomodulatory Culture supernatant [81]
4 Adenosine Immunomodulatory Mycelium [82]
5 Guanosine Immunomodulatory Mycelium [82]
6 Cordymin Antioxidant; Anti-inflammation - [83]
7 Lovastatin Hypolipidemic Mycelium [19]
8 γ-aminobutyric acid (GABA) Neurotransmitter Mycelium [19]
9 Sitosterol Cytotoxic Mycelium [85]
10 Ergosterol Cytotoxic Mycelium [85]
11 Ergosta-4,6,8(14),22-tetraen-3-one(ergone) Cytotoxic - [86]
12 5α,8α-epidioxy- 22E-ergosta-6,22-dien-3β-ol Cytotoxic Mycelium [85]
13 5α,8α-epidioxy-22E-ergosta-6, 9(11),22-trien-3β-ol Cytotoxic Mycelium [85]
14 5α,6α-epoxy-5α-ergosta-7,22- dien-3β-ol Cytotoxic Mycelium [85]
15 5α,8α-epidioxy-24(R)-methylcholesta-6,22-dien- 
3β-D- glucopyranoside
Antitumor Mycelium [87]
16 5,6-epoxy-24(R)-methylcholesta-7,22-dien-3β-ol Antitumor Mycelium [87]
17 Myriocin Immune inhibitor - [88]
18 Serine protease Fibrinolytic Culture supernatant [89]
19 Melanin Antioxidant Mycelium [2]
20 cordysinin A Anti-inflammatory Mycelium [90]
21 cordysinin B Anti-inflammatory Mycelium [90]
22 cordysinin C Anti-inflammatory Mycelium [90]
23 cordysinin D Anti-inflammatory Mycelium [90]
24 cordysinin E Anti-inflammatory Mycelium [90]
25 Cordyceamide A Cytotoxic Culture supernatant [91]
26 Cordyceamide B Cytotoxic Culture supernatant [91]
activities.[60] An acidic polysaccharide AEPS-1, fractionated from 
the EPS produced by C. sinensis Cs-HK1 in mycelial culture, was 
composed of glucopyranose (Glcp) and pyrano-glucuronic acid 
(GlcUp) in an 8:1 M ratio plus a trace amount of mannose, which 
has an average MW of 36 kDa and significantly stimulated the 
release of several major cytokines that may have immunomodula-
tory properties.[57]
The polysaccharide CPS-2, mostly composed of α-(1→4)-
d-glucose and α-(1→3)-d-mannose and branched with α-(1→4, 
6)-d-glucose every 12 residues, has an average MW of 43.9 kDa 
and has been shown to significantly relieve renal failure.[73] A 
polysaccharide with a MW of 82 kDa that was isolated from the 
culture medium of Cordyceps, namely cordysinocan, and contained 
glucose, mannose, and galactose in a 2.4:2:1 ratio induced cell 
proliferation and the secretion of interleukin (IL)-2, IL-6, and 
IL-8.[54] In another study, EPS consisting of mannose, glucose, and 
galactose in a ratio of 23:1:2.6 with a MW of about 104 kDa had 
the ability to stimulate cytokine expression in immunocytes.[56] 
Moreover, EPS composed of polysaccharide-protein complexes 
with a β-D-glucan backbone and a wide range of MWs (5 kDa to 
more than 200 kDa) had moderate antioxidant activities.[59]
Intracellular polysaccharides
Intracellular polysaccharides (IPS), extracted from O. sinensis 
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Table 2. Bioactivities, experimental modes, materials and extraction solvents of O. sinensis 
No. Bioactivity Experiment mode Material Extraction solvent References
1 Immunomodulatory In vivo Artificial CS＊1 - [92]
In vivo CS - [93]
In vivo CS Water [94]
In vivo CS Water [95]
In vivo CS - [96]
Ex vivo EPS＊2 - [97]
Ex vivo CS - [98]
Ex vivo EPS - [98]
In vitro CS - [99]
In vitro CS [100]
In vitro Mycelium - [101]
In vitro Mycelium Water [102]
In vitro Mycelium Methanol [103]
In vitro Mycelium Methanol [104]
In vitro Fruiting body Methanol [105]
2 Immunosuppression In vitro Mycelium - [106]
Clinical CS - [107]
3 Anticomplementary In vitro EPS - [108]
4 Antitumor In vitro Polysaccharide-rich fraction - [109]
Clinical CS - [110,111]
In vitro Mycelium Methanol [112]
In vitro Mycelium Methanol [113]
In vivo CS - [114]
In vitro CS Water [115]
In vitro Mycelium Ethyl acetate [116]
In vitro Mycelium Water [117]
5 Anti-inflammation In vivo Cordymin - [83]
In vitro Mycelium - [118]
In vitro Cordysinins A-E from mycelium - [90]
In vitro CS - [119]
In vitro Mycelium Methanol [112]
In vivo Extract - [120]
6 Antioxidation In vitro EPS - [108]
In vitro EPS - [109]
In vitro Mycelium Water [121]
In vitro Mycelium Water [122]
In vitro Fruiting body Water [123]
In vivo Cordymin - [83]
In vivo Mycelium - [124]
7 Antibacterial In vitro Mycelium - [125]
In vivo Mycelium - [126]
8 Hepatoprotection In vitro Fruiting body - [167]
In vivo Compound Codyceps-TCM-700C - [128]
In vivo The fruiting bodies - [129]
In vivo CS - [130]
In vivo CS - [131]
In vivo Mycelium - [132]
In vivo Mycelium - [133]
9 Kidneys benefits In vivo CS - [134]
In vivo CS - [135]
In vivo CS - [136]
In vivo CS - [137]
In vivo CS - [138]
In vitro CS - [139,140]
In vitro Natural product of CS (H1-A) - [141]
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No. Bioactivity Experiment mode Material Extraction solvent References
Clinical Bailing Capsule, fermented agent of CS - [142]
10 Antidiabetic In vivo Mycelium - [143]
In vivo CS - [144]
In vivo Vanadium-enriched CS (VECS). - [145]
In vivo Vanadium-enriched CS(VECS) - [146]
In vivo Fruiting body - [147,148]
In vivo Fruiting body - [149]
In vivo Mycelium(cordymax™ Cs-4) - [150]
In vivo Mycelium Sodium hydroxide [151]
11 Hypocholesterolemic In vivo Mycelium Water [152]
12 Antiarteriosclerosis In vivo Extract - [153]
In vivo Fruiting body Water [154]
13 Antithrombus In vivo Mycelium Alcohol [155]
14 Hypotensive and 
vasorelaxant
In vivo CS Phosphate buffer saline [156]
15 Lung benefit In vivo CS - [157]
In vivo CS - [158]
In vivo Cultured CS - [159]
In vivo CS Alcohol [146]
In vivo Mycelium - [160]
16 Photoprotection In vitro Mycelium - [161]
In vivo Mycelium Methanol [162]
In vivo Mycelium Water [163]
17 Antidepression In vivo Vanadium-enriched Mycelium - [145,146]
In vivo Mycelium Water [164]
Clinical Mycelium - [165]
18 Antiosteoporosis In vivo CS - [166]
19 Anticerebral ischemia In vivo Extract - [167]
20 Prevention and treatment 
of injury to the bowel
In vivo Extract Water [168]
21 Promotion to endurance 
capacity
In vivo Mycelium - [169]
Clinical Mycelium(cordymax™ Cs-4) - [63]
22 Antifatigue Clinical Cultured CS - [170]
23 Antiasthmatic In vitro Extract - [171]
24 Learning-memory 
Improvement
In vivo Extracts - [172]
25 Steroidogenesis In vitro CS - [173]
In vivo CS - [174]
In vitro Mycelium - [175]
In vitro Mycelium [176]
In vitro CS Water [177]
26 Erythropoiesis In vitro CS - [178]
27 Antiarrhythmic In vivo CS Alcohol [179]
28 Antiaging In vivo Extract - [180]
29 Allograft rejection 
prevention
In vivo CS - [181]
30 Lupus attenuation In vivo Mycelium - [182]
In vitro A pure compound (H1-A) from CS - [183]
31 Testosterone production In vivo CS - [176,184]
32 Sedation In vivo Natural CS - [185]
33 Adjunction Clinical CS - [186]
＊1CS: Cordyceps sinensis
＊2EPS: Extracellular polysaccharide
Table 2 (Contd...)
Lo, et al. / Journal of Traditional and Complementary Medicine 3 (2013) 16-32
24
mycelia and containing 1,3-β-D-, 1,3-α-D-, or 1,4-α-D-glucan with 
1,6-branched chains, had MWs ranging from 7.7 to 1180 kDa de-
pending on the extract conditions. Structural analyses showed that 
insoluble polysaccharides with 1, 3-β-D-glucan contained some 1, 
6-branched chains with an average particle diameter of 1.5 μm.[187] 
The D-glucan consisted of a backbone with (1→4)-D-glucosyl 
residues and carried a single (1→6)-linked D-glucosyl residue; and 
these α-D-glucosidic linkages were present in the polysaccharide 
with short exterior chains.[188] The neutral mannoglucan with a MW 
of 7.7 k Da consisted of Man and Glc units in the molar ratio of 
1:9, a α-D-glucan backbone with (1→4)- and (1→3)-linkages, and 
side chains of α-D-(1→6)-Manp, which attached to the backbone 
via O-6 of α-(1→3)-Glcp residues.[189] 
The polysaccharide CS-F10, purified from a hot water extract, 
was composed of galactose, glucose, and mannose in a molar ratio 
of 43:33:24, and its MW was estimated to be about 15 kDa, which 
has a comb-type structure with α-D-glucopyranosyl residues on the 
termini of the side-chains and characteristic sugar residues, such as 
1, 5-linked β-D-galactofuranosyl residues.[190] Hot water extracts 
of mycelia (WIPS) and alkaline extracts of mycelia (AIPS) were 
characterized as α-d-glucans with a backbone of (1→4)-linked 
α-D-Glcp and similar MWs (WIPS 1180 kDa; AIPS 1150 kDa); 
and WIPS had a short branch of (1→6)-linked α-D-Glcp, and AIPS 
was a linear glucan, which is distinct from the branched structures 
of most glucans from medicinal fungi.[61]
IPS from C. sinensis mycelia with MWs ranging from 8.1 to 
460 kDa have antioxidant, anti-inflammatory, immunomodulato-
ry, hypoglycemic, and hypocholesterolemic activities, described 
as following. Antioxidant polysaccharide CPS1 was found to 
be a glucomannogalactan with a monosaccharide composed of 
glucose, mannose, and galactose in a ratio of 2.8:2.9:1, and its 
total carbohydrate content and average MW were 99.0% and 
8.1 kDa, respectively.[72] The anti-inflammatory polysaccharide 
fraction CME-1, has a MW of 27.6 kDa and containing mannose 
and galactose in a ratio of 4:6.[191] The hypoglycemic polysac-
charides obtained from a hot-water extract and alkaline extracts 
were found to be composed of galactose, glucose, and mannose 
in a ratio of 62:28:10 with a MW 45 kDa.[67] In addition, the 
isolated IPS composed of D-Glc, D-Man, L-Ara, and D-Gal in a 
molar ratio of 8:90:1:1 with an average MW of 83 kDa has been 
shown to have immunomodulatory potential.[65] A polysaccharide 
with MW 210 kDa may protect against free radical-induced 
neuronal cell toxicity.[192] Another polysaccharide with a MW 
of 210 kDa that was isolated and named CSP-1 is composed of 
glucose, mannose, and galactose in the ratio of 1:0.6:0.75 and 
was shown to have strong antioxidation activity and the abili-
ties to decrease blood glucose and insulin secretion in diabetic 
animals.[68] The heteropolysaccharide PS-A, composed of D-
glucose, D-galactose, and D-mannose in a molar ratio of 2:1:1 
with a MW of 460 kDa, was shown to possess strong inhibitory 
activity against cholesterol esterase and may be a potential agent 
to control hypercholesterolemia.[74]
Nucleosides
It has been demonstrated that the nucleoside contents, includ-
ing uracil, uridine, hypoxanthine, inosine, guanosine, adenosine, 
adenine, and cordycepin, of natural and cultured Cordyceps could 
be separated into two individual sub-groups, which suggested that 
the chemical characteristics of the cultured mycelia of different 
fungal strains isolated from natural C. sinensis were similar but 
were different from natural mycelia.[193] The perithecium of C. 
sinensis was found to have considerably higher amounts of total 
nucleosides and nucleobases compared to other parts of this fun-
gus.[194] The content of the four active nucleosides, specifically 
adenosine, guanosine, cytidine, and thymidine, in C. sinensis 
was lower than that of cultured Cordyceps.[195] Moreover, there is 
a positive correlation between nucleoside content in C. sinensis 
and the growth altitude.[46]
Adenosine
Adenosine was abundant in the fruiting body and was consider-
ably more abundant than in the corpus of natural DongChongXi-
aCao and the mycelia of C. sinensis.[196] It has been shown that 
the amount of adenosine in Cordyceps ranges from 0.28 to 14.15 
mg/g.[197] The concentration of adenosine 2.45 ± 0.03 mg/g in 
C. militaris fruiting bodies was found to be higher than those of 
1.643 ± 0.03 mg/g in natural C. sinensis, while the content of the 
fermented mycelia 1.592 ± 0.03 mg/g of C. militaris was similar 
to those of natural C. sinensis.[198] 
Cordycepin
Studies have shown that cordycepin is abundant in cultured C. 
militaris (2.28 ± 0.84 mg/g) and sparse in natural C. sinensis; how-
ever, there is an undetectable amount in cultured C. sinensis.[199] The 
amount of cordycepin in Cordyceps was found to range from 0.006 
mg/g to 6.36 mg/g.[196] In cultured mycelia and the fruiting body of 
Cordyceps, cordycepin contents were lower and varied from 0.006 to 
1.64 mg/g.[196,198] The cordycepin content of the mycelia of C. sinensis 
cultured in potato dextrose agar (PDA) medium and Finger millet 
medium were 0.075 mg/g and 0.021 mg/g, respectively; however, 
the cordycepin content in natural C. sinensis was higher than in the 
mycelia cultured with PDA medium.[200] It has been indicated that the 
concentration of cordycepin in C. militaris fruiting bodies is higher 
than in natural C. sinensis, and the concentration of cordycepin in 
fermented C. militaris mycelia is similar to that in natural C. sinensis: 
the mean cordycepin contents in the fruiting bodies of C. militaris 
and C. sinensis were found to be 2.65 and 1.64 mg/g, respectively, 
and the content in C. militaris mycelia was 1.59 mg/g.[198] In addition, 
cultured mycelia and natural specimens of C. sinensis contained simi-
lar amounts of cordycepin.[42] When extracted with 50% methanol-
chloroform, the cordycepin content of cultured mycelia varied from 
0.002% to 0.029% (i.e., 0.02-0.29 mg/g) in twenty-one isolates, and 
the cordycepin content of natural Dong Chong Xia Cao varied from 
0.004% to 0.006% (i.e., 0.04-0.06 mg/g).[201]
Mannitol
Mannitol is the so-called “ChongCao Acid” in Chinese and is 
also improperly named as “cordycepic acid.” When searching for 
the terms “mannitol” plus “Cordyceps” in the Scopus database, 
a limited number of articles can be found. Li et al,[202] indicated 
that the D-mannitol contents in natural fruiting bodies of C. si-
nensis, mycelia from shaking cultures, and fruiting bodies from 
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artificial cultivation of H. beakdumountainsi were 8.9, 11.5, and 
10.2%, respectively. For in vitro-cultured C. sinensis, the amount 
of D-mannitol yielded was almost the same as that in natural 
samples.[42] Moreover, when C. sinensis was cultured with mil-
let, the D-mannitol content achieved levels as high as that in C. 
militaris fruiting bodies.[203] There was no obvious difference in 
the amount of nucleosides between cultured O. sinensis mycelia 
and natural products; however, natural products were shown to 
have a significantly higher D-mannitol content compared with 
submerged culture mycelia.[204] 
Likewise, when searching for the terms “cordycepic acid” 
plus “Cordyceps” in the Scopus database, a limited articles can be 
found. The chemical constituents of natural Cordyceps, including 
cordycepic acid, have been described.[13] Dong et al.[205] showed 
that the superoxide dismutase activity and the content of cordy-
cepic acid in the fruiting bodies of C. militaris were dependent on 
the sodium selenite concentration in the culture medium. It has 
been reported that C. sinensis has many bioactive components, 
such as 3′-deoxyadenosine, cordycepic acid, and Cordyceps 
polysaccharides.[3] In addition, yields of cordycepic acid from 
C. jiangxiensis, C. taii, and C. gunnii were found to be 11.81%, 
8.72%, and 4.73%, respectively, of the dry weight of mycelia.[206]
Amino acids
The total amount of amino acids in fermented mycelia 
was determined to be 9.23%, which is lower than that in wild 
DongChongXiaCao (18.1%) but is similar to that in the fruiting 
body of wild DongChongXiaCao.[46] The three principal amino 
acids in the corpus-fruiting body are glutamic acid, aspartic acid, 
and arginine, and their contents are 2.64–2.66%, 1.70–1.84%, and 
1.53–1.60%, respectively.[46] A mixture with 18 synthetic amino 
acids to mimic the amino acid composition in natural C. sinensis 
showed the same sedative action as natural C. sinensis.[185]
Sterols
The ergosterol content in the stroma of C. sinensis was found 
to be approximately 0.92 g/L and was about three times higher than 
that found in the sclerotium.[207] The fruiting body (CsA) and the 
host caterpillar (CsB) of C. sinensis had similar ergosterol composi-
tions, but the level of ergosteryl esters in CsB was much higher than 
in CsA, these data indicated that CsA and CsB might exist in differ-
ent growth phases and have different physiological functions for the 
growth and multiplication of C. sinensis.[208] It has been shown that 
ergosta-4,6,8(14),22-tetraen-3-1 may induce G2/M cell cycle arrest 
and apoptosis in human hepatocellular carcinoma HepG2 cells.[86] 
5α,8α-epidioxy-22E-ergosta-6,22-dien-3β-ol, 5α,8α-epidioxy-22E-
ergosta-6,9(11),22-trien-3β-ol, and 5α,6α-epoxy-5α-ergosta-7,22-
dien-3β-ol isolated from the ethyl acetate fraction with a peroxide 
ring or an epoxide ring had substantial cytotoxic activity.[209] In 
addition, 5α,8α-epidioxy-24(R)-methylcholesta-6, 22-dien-3β-D-
glucopyranoside, and 5,6-epoxy-24(R)-methylcholesta-7,22-dien- 
3β-ol from the methanol extract of C. sinensis had antitumor 
activity.[87]
Aurantiamides
Two aurantiamides, a new class of potent analgesic and anti-
inflammatory agents, named cordyceamides A and B were isolated 
from the culture liquid of C. sinensis along with one known com-
pound, aurantiamide acetate. The structures of these compounds 
were elucidated as N-benzoyl-l-tyrosinyl-l-phenylalaninol acetate and 
N-benzoyl-l-tyrosinyl-l-p- hydroxyphenylalaninol acetate by 1D and 
2D-NMR techniques and by the comparison with the literature.[91]
Peptides
Cyclodipeptides
A cyclodipeptide named cordycedipeptide A, which is a natural 
compound that was isolated from the culture liquid of C. sinensis, 
had cytotoxic activity against L-929, A375, and Hela cells.[210]
Cordymin
The peptide cordymin from C. sinensis, which has a neuropro-
tective effect in the ischemic brain due to inhibited inflammation 
and increased antioxidant activity related to lesion pathogenesis, 
can be used as a potential preventive agent against cerebral 
ischemia-reperfusion injury.[83]
Myriocin
Myriocin (also known as the antibiotic ISP-1) is a new type 
of immune inhibitor extracted from C. sinensis, it was shown 
to significantly inhibit the upregulated expression of cyclin D1 
induced by high concentrations of glucose, restoring the expres-
sion of cyclin D1.[88]
Melanin
The antioxidant activity of melanin, derived from a black 
pigment, was isolated from the fermentation broth of O. sinensis 
and showed much stronger scavenging abilities for 1,1-diphenyl-
2-picrylhydrazyl (DPPH•) and ferrous ion chelation compared to 
the mycelial water extract.[211]
Lovastatin, γ-aminobutyric acid (GABA), and ergothioneine
Lovastatin, GABA, and ergothioneine are secondary metabo-
lites of fungal growth. Chen et al.[84] indicated that mycelia of C. 
sinensis contained 1365 mg/kg of lovastatin, 220.5 mg/kg GABA, 
and detectable ergothioneine and had different hypolipidemia, 
hypotension, and antioxidant activities.
Cordysinins
Five cordysinins, A-E, from the mycelia of C. sinensis have 
been identified and have been shown to have anti-inflammatory 
activities, and 1-(5-Hydroxymethyl-2-furyl)-β-carboline was 
shown to most significantly inhibit superoxide anion generation 
and elastase release.[90]
SHAKING CULTURE AND SUBMERGED 
FERMENTATION OF O. SINENSIS
The maximal production of mycelia, EPS, and exo-biopolymer 
are important concerns for producers, especially for industry. Sev-
eral factors that may affect the production of O. sinensis in shaking 
culture and submerged fermentation, including strain, medium, 
and culture conditions, have been discussed in different studies. 
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The amounts of mycelial biomass, EPS, and exo-biopolymer 
range from 11.10 to 62.3 g/l, 0.43 to 3.21 g/l and 22.0 to 28.4 g/l, 
respectively, described as follows. 
It has been observed that Tween 80 can exhibit a remarkable ef-
fect on EPS production by increasing EPS yield more than two-fold 
at 1.5% (w/v); the effects of Tween 80 can probably be attributed 
to the stimulation of EPS biosynthesis and release from fungal 
cells.[212] In addition, evidence has shown that palmitic acid may 
significantly increase the production of biomass and extracellular 
polysaccharides to 11.10 g/l and 0.43 g/l, respectively.[191] Adding 
ammonium to the mycelial culture of strain Cs-HK1 may enhance 
intracellular cordycepin accumulation, which may be attributed to 
the uptake of ammonia for nucleoside synthesis, and EPS produc-
tion, which may be attributed to the increased uptake of glucose 
for EPS biosynthesis.[213]
The optimal medium for the production of mycelia and exo-
biopolymers by strain CS 16 is 2% sucrose, 0.9% yeast extract, 
0.3% K2HPO4, and 0.4% CaCl2, and this medium was shown to 
yield maximal mycelia and exo-biopolymer productions of 54.0 
g/l and 28.4 g/l, respectively, in shaking-flask cultures.[214] In 
bioreactor cultures, rapid differentiation and cell lysis occurred 
when agitation speed was increased. When the agitation speed 
was maintained at 350 rpm, 62.3 g/l of mycelia and 22.0 g/l of 
exo-biopolymers were obtained from strain CS 16 in submerged 
fermentation.[215] In shaking cultures, the maximum polysaccharide 
production was 3.05 and 3.21 g/l in a flask and a 5-L jar fermentor, 
respectively, when fungi were supplied with optimal medium.[216] 
It is believed that the optimal medium for mycelial growth is 50 
g/l sucrose, 10 g/l peptone, and 3 g/l yeast extract, which would 
produce over 22 g/l of mycelial biomass after 40 days of submerged 
culture at a temperature below 20°C.[217]
CULTURE AND BIOACTIVITY OF 
HIRSUTELLA SINENSIS OR HIRSUTELLA SP.
There is little literature published on H. sinensis, the anamorph 
of O. sinensis. This might be due to geographic limitations, dif-
ficulty in isolation and cultivation, and slow growth under low 
temperatures.
Culture
It was shown that most strains of H. sinensis prefer to grow on 
Sabouraun’s dextrose agar, and some of the strains prefer potato-
dextrose agar as the medium for optimal development.[218] The 
optimized conditions and medium for submerged fermentation 
of Hirsutella sp. have been described as follows: initial pH 5.5, 
potato extract 20% (w/v), sucrose 2.5%, peptone 0.5%, K2HPO4 
0.2%, MgSO4 0.05%, and fermentation for 4 days, the highest 
production of EPS and mycelial biomass may reach 2.17 and 
10.06 g/l, respectively.[49]
Bioactivity
H. sinensis extract (HSW) was shown to have a remarkable 
action in vitro and in vivo in a model of kidney injury;[219] the extract 
downregulated transforming growth factor-β1 in renal tissue, an-
tagonized tubular epithelial-myofibroblast transdifferentiation and 
renal interstitial fibrosis, and improved renal function in chronic 
aristolochic acid nephropathy rats.[220] Furthermore, the fermented 
mycelia of H. sinensis significantly prevented spontaneous type 1 
diabetes in non-obese diabetic mice.[221] Additionally, H. sinensis 
was shown to significantly increase animal survival after a lethal 
dose of radiation, accelerate leukocyte recovery, and stimulate 
immune lymphocyte proliferation.[222]
ECOLOGY AND HOSTS
O. sinensis is confined to the Tibetan Plateau and its surround-
ing regions, including Tibet, Gansu, Qinghai, Sichuan, and Yunnan 
provinces in China, in certain areas of the southern flank of the 
Himalayas, and in the countries of Bhutan, India, and Nepal. These 
regions are at altitudes of over 3,000 m. The fungus is distributed 
from the southernmost site in Yulong Naxi Autonomous County 
in northwestern Yunnan Province to the northernmost site in the 
Qilian Mountains in Qilian County, Qinghai Province and from the 
east edge of the Tibetan Plateau in Wudu County, Gansu Province 
to the westernmost site in Uttarakhand, India.[202] The yearly yield 
of C. sinensis in the Naqu district, which is the principal growth 
zone in Tibet, is 7000 kg, and the elevation of the distribution 
area is from 5000 m to 4100 m, and the ecological geographical 
distribution is mainly affected by vegetation, soil, temperature, 
and humidity.[223]
As hosts, the larvae of Thitarodes spp. play a vital role in sup-
plying nutritional materials for the growth of O. sinensis. In the 
Tibetan Plateau, more than 40 species of the genus Thitarodes have 
been recorded since 1958.[224] According to another publication, 57 
taxa are recognized as potential hosts of O. sinensis, including 1 
Bipectilus, 1 Endoclita, 1 Gazoryctra, 12 Hepialus, 2 Magnificus, 
3 Pharmacis, and 37 Thitarodes.[225] The recorded altitude ranges 
of the recognized potential host insects were found to vary from 
2800 to 5100 m, and the distribution areas of these species covered 
26 provinces in China and more than 12 other countries.[225] Due to 
long-term adaptive evolution, O. sinensis and its host insects have 
developed a living requirement for special high altitude-associated 
climates and soil conditions, such as sub-ambient atmosphere and 
soil temperatures and specific solar radiation, barometric pressure, 
and hypoxic conditions.[224] Studies show that there is genetic 
differentiation of C. sinensis among different latitudes.[226] The 
interspecific genetic differentiations are obvious in Hepialu, and 
the genus Hepialus might be considered the polyphyletic origin for 
Cytb sequences, which have abundant variations among the host 
insects of C. sinensis at both the specific and generic levels.[227]
CONCLUSIONS
O. sinensis is a complex fungus with multiple biological 
functions. Over 20 bioactive ingredients have been found in O. 
sinensis, such as extracellular polysaccharides, intracellular poly-
saccharides, cordycepin, adenosine, and sterols, derived from its 
mycelia, culture supernatant, or fruiting body. In addition, over 
30 bioactivities have been indicated, including immunomodula-
tory, antitumor, anti-inflammation, and antioxidant activities, in 
preparations or solvent extracts in in vitro, in vivo, or ex vivo stud-
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ies. However, few publications have given regard to the bioactive 
ingredients, bioactivities, and the medium and culture conditions 
of O. sinensis and H. sinensis, which must be incubated for more 
than 10 days at low temperatures (below 21°C ). The slow growth 
rate at low temperature is a critical characteristic of O. sinensis and 
H. sinensis. It has been demonstrated that these fungi grow poorly 
at temperatures above 21°C and stop growing at 25°C or above. 
The fungus O. sinensis is not equivalent to the traditional Chi-
nese medicine DongChongXiaCao; the latter develops a fruiting 
body following the occupation of a dead caterpillar and grows wild 
in nature. The host caterpillar provides nutrients for O. sinensis, re-
sulting in the formation of a fruiting body in the appropriate climate 
and environment. The morphology of O. sinensis in submerged 
culture can be microscopically visualized as mycelia, without the 
fruiting body. The relationship between O. sinensis and its host in 
the traditional Chinese medicine DongChongXiaCao, as well as 
its pathobiology and ecology, still remains unclear. 
The mysterious caterpillar fungus O. sinensis has been re-
named since 2007; however, many publications still use the name 
C. sinensis. When the names “Ophiocordyceps sinensis” and 
“Cordyceps sinensis” are searched for in article titles, abstracts, 
and keywords in the Scopus database from the year 2008 to 2012, 
84 and 255 articles can be found, respectively. Even though it has 
been confirmed that H. sinensis is the anamorph of C. sinensis, 
most articles still use the terms “Cordyceps sinensis,” “Cordyceps,” 
and “Cordyceps” to refer to the traditional Chinese medicine 
DongChongXiaCao. Among all of these publications, not one 
successfully obtained fruiting bodies from caterpillars artificially 
infected with O. sinensis or H. sinensis. The key identification 
characteristics for O. sinensis are the existence of a perithecium, 
ascus, and ascospore in the fruiting body. If the fruiting body can-
not be formed from caterpillars infected by O. sinensis or H. sinen-
sis, these key characteristics cannot be identified by microscope. 
Beginning January 1st, 2013, regulations will allow one fungus to 
have only one name, and the system of permitting separate names 
for anamorphs will end.[228] The anamorph name H. sinensis will 
be changed by the International Code of Nomenclature for algae, 
fungi, and plants (formerly called the International Code of Bo-
tanical Nomenclature)[229] to O. sinensis.
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